PINI, Laura
 Distribuzione geografica
Continente #
NA - Nord America 6.495
EU - Europa 3.647
AS - Asia 3.318
SA - Sud America 258
AF - Africa 53
OC - Oceania 30
Continente sconosciuto - Info sul continente non disponibili 12
Totale 13.813
Nazione #
US - Stati Uniti d'America 6.436
SG - Singapore 1.079
CN - Cina 912
IT - Italia 812
UA - Ucraina 787
HK - Hong Kong 607
DE - Germania 465
FI - Finlandia 322
GB - Regno Unito 291
BR - Brasile 234
IN - India 226
PL - Polonia 225
IE - Irlanda 213
RU - Federazione Russa 205
TR - Turchia 189
FR - Francia 77
ID - Indonesia 76
VN - Vietnam 57
SE - Svezia 46
BE - Belgio 39
CA - Canada 36
JP - Giappone 34
AT - Austria 32
AU - Australia 25
NL - Olanda 24
EG - Egitto 22
MX - Messico 20
IL - Israele 19
KR - Corea 19
IR - Iran 18
CZ - Repubblica Ceca 17
DK - Danimarca 14
TW - Taiwan 14
ES - Italia 13
MU - Mauritius 13
EU - Europa 12
GR - Grecia 10
SA - Arabia Saudita 10
AR - Argentina 9
MY - Malesia 7
NO - Norvegia 7
PE - Perù 7
PT - Portogallo 7
CH - Svizzera 6
IQ - Iraq 6
MK - Macedonia 6
AE - Emirati Arabi Uniti 5
CY - Cipro 5
RO - Romania 5
ZA - Sudafrica 5
AZ - Azerbaigian 4
MA - Marocco 4
PK - Pakistan 4
UZ - Uzbekistan 4
BG - Bulgaria 3
BY - Bielorussia 3
KG - Kirghizistan 3
LV - Lettonia 3
NA - Namibia 3
NZ - Nuova Zelanda 3
OM - Oman 3
TH - Thailandia 3
CD - Congo 2
CL - Cile 2
CO - Colombia 2
EC - Ecuador 2
EE - Estonia 2
FJ - Figi 2
HR - Croazia 2
HU - Ungheria 2
IM - Isola di Man 2
JO - Giordania 2
KE - Kenya 2
LK - Sri Lanka 2
LT - Lituania 2
PA - Panama 2
AL - Albania 1
BD - Bangladesh 1
BO - Bolivia 1
DZ - Algeria 1
GE - Georgia 1
IS - Islanda 1
JM - Giamaica 1
KW - Kuwait 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
MD - Moldavia 1
NG - Nigeria 1
NP - Nepal 1
PH - Filippine 1
PS - Palestinian Territory 1
QA - Qatar 1
SK - Slovacchia (Repubblica Slovacca) 1
TJ - Tagikistan 1
VE - Venezuela 1
Totale 13.813
Città #
Singapore 646
Fairfield 600
Hong Kong 594
Jacksonville 584
Woodbridge 548
Ashburn 480
Chandler 449
Houston 382
Princeton 364
New York 305
Wilmington 269
Brescia 251
Ann Arbor 234
Cambridge 231
Seattle 226
Warsaw 224
Dublin 188
Helsinki 188
Nanjing 172
Istanbul 171
Chicago 118
Los Angeles 116
Nanchang 90
Milan 84
Beijing 77
Des Moines 76
Moscow 74
Jakarta 65
Shanghai 64
Verona 63
San Diego 61
Salt Lake City 55
Shenyang 55
Buffalo 53
Dong Ket 53
The Dalles 53
Lancaster 50
Changsha 49
Hebei 49
London 49
Jinan 46
Brussels 39
Jiaxing 37
Tianjin 37
Washington 33
Nuremberg 30
Lappeenranta 29
Munich 29
Manchester 27
Hangzhou 25
San Francisco 23
Kunming 22
Tampa 22
Frankfurt am Main 21
Pune 20
Düsseldorf 19
Guangzhou 18
Zhengzhou 18
Elk Grove Village 17
Trento 17
Menlo Park 15
Rome 15
Romola 15
São Paulo 15
Azzano 14
Gurugram 14
Haikou 14
Tel Aviv 14
Vienna 13
Lanzhou 12
Sommacampagna 12
Tokyo 12
Toronto 12
Copenhagen 11
Mexico City 11
Norwalk 11
Taizhou 11
Al Mansurah 10
Dearborn 10
Rozzano 10
Sydney 10
Genoa 9
New Bedfont 9
Ningbo 9
Philadelphia 9
Phoenix 9
Riyadh 9
Santa Clara 9
Cazzago San Martino 8
Curitiba 8
Melbourne 8
Portsmouth 8
Sterling 8
Taiyuan 8
Atlanta 7
Belo Horizonte 7
Fuzhou 7
Hounslow 7
Islington 7
Miami 7
Totale 9.403
Nome #
Twice-Yearly Depemokimab in Severe Asthma with an Eosinophilic Phenotype 831
Severe asthma: One disease and multiple definitions 272
Central airways remodeling in COPD patients 152
Il deficit di Alfa1-Anti-tripsina. 149
Alpha1-antitrypsin deficiency-associated cervical artery dissection. Report of three cases. 129
Exercise tolerance in obstructive sleep apnea-hypopnea (OSAH), before and after CPAP treatment: Effects of autonomic dysfunction improvement 128
Methods for Measuring Lung Volumes: Is There a Better One? 127
Acute dynamic hyperinflation and systemic inflammation in stable COPD patients. 126
Vitamin D and health status in elderly. 124
Airway remodeling in allergen-challenged Brown Norway rats: Distribution of proteoglycans 119
Evaluating the Emergency Department admission and hospitalization trend for COPD Exacerbation and time-dependent Particulate Matter exposure 116
Long-term physical training leads to airway remodelling in animal model. 116
Tidal airway closure during bronchoconstriction in asthma: usefulness of lung volume measurements. 115
Alpha1-antitrypsin deficiency: a twenty-five years' experience. 114
Cardiac Sympathetic Hyperactivity in Patients with Chronic Obstructive Pulmonary Disease and Obstructive Sleep Apnea 111
The role of bronchial epithelial cells in the pathogenesis of COPD in Z-alpha-1 antitrypsin deficiency. 109
Epatocirrosi e versamento pleurico recidivante (idotorace epatico). 104
Inspiratory drive is related to dynamic pulmonary hyperinflation in COPD patients 104
Diagnostic flow chart for targeted detection of alpha-1-antitrypsin deficiency 102
The role of alpha-1-antitrypsin (AAT) Z polymers in the lung of patients with alpha-1-antitrypsin deficiency (AATD). 101
Skin prick-test reactivity to aeroallergens and allergic symptoms in an urban population of central Italy: a longitudinal study. 100
Alpha1-antitrypsin deficiency. The Brescia (Italy) clinical study [Il deficit di alfa1-antitripsina: Lo studio clinico di Brescia] 100
Diagnostic flow chart for targered detection of Alpha-1-antitrypsin deficiency. 100
Alpha1-Antitrypsin Deficiency in Spontaneous Cerebral Arterial Dissection. 99
Sex Differences in Severe Asthma: Results From Severe Asthma Network in Italy-SANI 99
Volume effect and exertional dyspnoea after bronchodilator in patients with COPD with and without expiratory flow limitation at rest. 97
Predictors of nocturnal oxyhemoglobin desaturation in COPD. 95
Changes in Smad expression and subcellular localization in bleomycin-induced pulmonary fibrosis. 94
Characteristics and treatment regimens across ERS SHARP severe asthma registries 94
Mild to moderate chronic airways disease does not carry an excess risk of cognitive dysfunction 93
Dose-Response curve to salbutamol during acute and chronic treatment with formoterol in COPD. 93
Daytime approach to Obstructive Sleep Apnea phenotyping 92
Impact of Particulate Matter on Emergency Department admissions and hospitalizations for COPD Exacerbation 92
Oral CorticoSteroid sparing with biologics in severe asthma: A remark of the Severe Asthma Network in Italy (SANI) 90
Tidal airway closure in asthma and COPD 89
Airway obstruction or closure during bronchoconstricction in asthma: can we preconize it? 88
Phenotyping OSAH patients during wakefulness 88
Predictors of exercise-induced airways obstruction in patients with mild asthma 87
COVID-19 in Severe Asthma Network in Italy (SANI) patients: clinical features, impact of comorbidities and treatments 87
Pulmonary rehabilitation improves functional outcomes and quality of life in post-SARS-CoV-2 mild-to-moderate infection patients: a pilot study 86
Alpha1-antitrypsin deficiency and arterial dissection: report of four cases 86
RETROSPECTIVE ANALYSIS AND RESULTS OF THE ALPHA1-ANTITRYPSIN DEFICIENCY CENTER ACTIVITY IN BRESCIA 86
Alpha1-antitrypsin Deficiecy and nephropathy 84
Angiotensin II - receprot (AT1) blockade reduces ventricul arrhythimias in uncomplicated essential hypertensive patients. 84
Alpha1-antitrypsin deficiency and abdominal aortic aneurysms: does this association really exist? 84
Diagnostic flow chart for targeted detection of Alpha1-antitrypsin deficiency. 83
Effect of PEEP on induced constriction is enhanced in decorin-deficient mice 82
Do GOLD stages of COPD severity really correspond to differences in health status? 82
Consequences of SARS-COV-2 Pneumonia on Lung function 82
Dynamic pulmonary hyperinflation and low grade systemic inflammaton in stable COPD patients. 80
Alpha1-antitrypsin deficiency and asthma 80
Early effects of CPAP on elastic aortic properties. 79
Dyspnea during night-time and at early morning in patients with stable copd is associated with supine tidal expiratory flow limitation 78
Effects of short-term exposure to Particulate Matter on Emergency Department admissions for Asthma Exacerbation 78
L'anziano di fronte ai problemi chirurgici: " I fattori di rischio" respiratori. 77
Alpha-1-antitrypsin deficiency - The Brescia Clinical Study. 77
Phenotyping-based treatment improves obstructive sleep apnea symptoms and severity: a pilot study 77
Role Of Particulate Matter On Emergency Department Visits For Asthma Exacerbation 77
Use of narrative medicine to identify key factors for effective doctor-patient relationships in severe asthma 77
ASSESSMENT OF RESPIRATORY FUNCTION IN PATIENTS AFTER SARS-COV-2 LUNG DISEASE 76
Late Breaking Abstract - Lung function tests in patients with previous SARS-COV2 pneumonia: a useful follow-up tool 76
Role of respiratory mechanics in the pathogenesis of airway hyperresponsiveness in obese subject. 74
COPD EXACERBATION AND AIRBORNE POLLUTANTS: CHARACTERIZING THE ROLE OF PARTICULATE MATTER AND FINE PARTICULATE MATTER SHORT-TERM EXPOSURE 74
Deficit di Alfa1-antitripsina. 73
Assessment of expiratory flow limitation in subjects with severe alpha-1-antitrypsin deficiency. 73
Effect of training on airways inflammatory response and remodeling in a rat model. 73
Inhaled corticosteroids in COPD: Trying to make a long story short 73
A Six-Month Follow-Up Evaluation of Lung Function in Patients with Previous SARS-COV-2 Pneumonia 73
Emergency department visits for Asthma Exacerbation after short-term exposure to Particulate Matter: trend assessment in a European industrial city. 73
ELASTIC PROPERTIES OF THE ASCENDING AORTA IN PATIENTS WITH ALPHA1-ANTITRYPSIN DEFICIENCY (Z-HOMOZYGOTES) 72
Emergency department admission and hospitalization for COPD exacerbation and particulate matter short-term exposure in Brescia, a highly polluted town in northern Italy 72
Diagnosing pneumothorax through standardized bilateral ultrasound images comparison 72
Echocardiographic evaluation in subjects with (1)-Antitrypsin deficiency 71
Effects of Chronic and Acute Pulmonary Hyperinflation on Phrenic Nerve Conduction in Patients with COPD 71
SMALL AIRWAYS DISEASE AND Z-ALPHA1-ANTITRYPSIN POLYMERS: IS THERE A CORRELATION? 70
Intra-epithelial polymerization, accumulation and secretion of alpha-1-antitrypsin (AAT) Z polymers in the lung of patients with alpha-1-antitrypsin deficiency (AATD). 69
Z-alpha1-antitrypsin polymers and small airways disease: a new paradigm in COPD development? 69
Assessment of Small Airway Dysfunction and Z-Alpha1-Antitrypsin Polymers in Exhaled Breath Condensate in Healthy PiZZ Subjects 68
A prospective evaluation of lung function at three and six months in patients with previous SARS-COV-2 pneumonia 68
Il deficit di alfa-1-antitripsina: lo studio clinico di Brescia. 67
Valutazione ecocardiografica in una popolazione di pazienti con deficit di alfa1-antitripsina (genotipo ZZ). 67
Time-Dependent Relationship Between Particulate Matter Exposure and COPD Exacerbations 67
Alpha1-antitrypsin deficiency in spontaneous cerebral arterial dissection 66
CHARACTERIZATION OF THE AIRWAY WALL COMPLIANCE AFTER TREATMENT WITH BRONCHODILATOR IN COPD PATIENTS 66
Assessment of expiratory flow limitation in subjects with severe alpha-1-Antitrypsin deficiency. alpha-1-antitrypsin deficiency - the biochemical basis of pulmonary emphysema. 65
Effect of precedine inspiratory speed and end-inspiratory on forced expiratory manoeuvre in healthy subjects and chronic obstructive pulmonary disease patients. 65
Chronic rhinosinusitis with nasal polyps impact in severe asthma patients: Evidences from the Severe Asthma Network Italy (SANI) registry 65
EVALUATION OF LUNG FUNCTION AFTER SARS-COV-2 PNEUMONIA 65
COPD: It is time to change! 64
Longitudinal Study of the Respiratory Function in Preterm Born Children: Comparison Between Subjects with and without Bronchopulmonary Dysplasia 64
Frequency of tiotropium bromide use and clinical features of patients with severe asthma in a real-life setting: Data from the severe asthma network in Italy (sani) registry 63
Role of sighs and breathing pattern in the pathogenesis of airway hyperresponsiveness in healty obese subjects. 62
Respiratory mechanics in pathogenesis of AHR in obese subjects. 62
Treatment of essential hypertension with hydrochlorothiazide combined with ACE-I or K+channel-I. 61
Vasodilators and diuretics control orthopnea also by reversing expiratory flow limitation in subjects with chronic heart failure. 61
EXERCISE-INDUCED ASTHMA: RESEARCHING PREDICTORS IN SUBJECTS WITH MILD ASTHMA 61
CHARACTERIZATION OF THE IMPACT OF PARTICULATE MATTER AND FINE PARTICULATE MATTER ON ASTHMA EXACERBATION 61
Evaluation of a New Strategy to Predict Exercise-Induced Asthma 60
Standardizing Bilateral Ultrasound Images Comparison for the Diagnosis of Pneumothorax: A Pilot Study 60
Z-alpha1-antitrypsin polymers and small airways disease: a new paradigm in alfa-1 anti-trypsin deficiency-related COPD development? 60
Totale 9.417
Categoria #
all - tutte 88.062
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 88.062


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020164 0 0 0 0 0 0 0 0 0 0 36 128
2020/20212.202 71 166 53 197 197 268 100 243 295 238 238 136
2021/20221.469 68 168 46 165 29 101 55 132 95 175 123 312
2022/20231.326 208 109 60 88 85 320 2 177 134 6 44 93
2023/20241.719 69 25 156 164 86 426 56 88 362 35 29 223
2024/20253.976 14 68 75 581 429 385 377 217 585 417 828 0
Totale 14.357